Search Results 471-480 of 17038 for pharmacogenetics
As scientists at the Mayo Clinic Center for Individualized Medicine discover new ways to use genomic information in the diagnosis, treatment and prevention of ...
Mayo Clinic researchers studying the genetics of people who had recently developed dilated cardiomyopathy, one of the most common causes of heart failure, have ...
About this study. The primary objective of the study is to utilize comprehensive, family-centered genomic screening strategies - chromosomal microarray ...
Durvalumab+/- Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (Caspian) · Overview.
Aim 1: To determine the metabolic effects of decreasing circulating EOS in healthy subjects. Mepolizumab is an FDA-approved drug that selectively reduces ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.
The research of Geoffrey Johnson, M.D., Ph.D., a Mayo Clinic nuclear medicine specialist & thoracic radiologist, focuses on radiopharmaceutical cancer ...
Dr. Ling's lab seeks to define the role of phosphoinositide signaling in cell migration, epithelial morphogenesis, and the assembly and function of primary ...
The Mayo Clinic Center for Individualized Medicine has achieved a milestone, finishing study recruitment after enrolling more than 100,000 participants in a ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.